首页> 美国卫生研究院文献>The Pan African Medical Journal >Hépatite virale B: aspects cliniques paracliniques et évolutifs dans le service d’Hépato Gastroentérologie de l’Hôpital Aristide Le Dantec: à propos de 728 cas
【2h】

Hépatite virale B: aspects cliniques paracliniques et évolutifs dans le service d’Hépato Gastroentérologie de l’Hôpital Aristide Le Dantec: à propos de 728 cas

机译:乙型病毒性肝炎:阿里斯蒂德·勒丹特克医院肝消化科的临床副临床和进行性研究:约728例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Viral Hepatitis B is a major public health problem in sub-Saharan Africa accounting for approximately 65 million of chronic carriers and 56.000 deaths per year. Our study aims to investigate the epidemiological paraclinical, therapeutic and evolutionary features of viral hepatitis B in patients followed up in our Department and to describe their serological profiles. We conducted a retrospective, longitudinal study in the Hepatogastroenterology Department at the Aristide Le Dantec Hospital in Dakar from 2010 to 2014. We included all HBsAg positive patients followed up on an ambulatory basis or hospitalized. We collected data from 728 medical records of patients infected with Hepatitis B virus: 7 cases of acute hepatitis, 442 cases of chronic infections, 161 cases of cirrhosis and 118 cases of hepatocellular carcinoma. The average age of patients was 33 years [14 - 83 years] with a sex ratio of 2.2. The circumstances in which it was diagnosed included systematic screening (26.2%), right hypochondrium pain (23%) and donation of blood (18.6%). Fifty nine were Hepatitis B virus mono-infected and had chronic active hepatitis. Inactive carriers were 118. Serological status was undetermined in 252 patients due to clinical examination inadequacy related to economic constraints. Antiviral Hepatitis B treatment wasn’t performed in 58 patients. Patients’ virologic and biochemical response after 120 weeks of treatment with Tenofovir was 85% and 100% respectively. Hepatitis B virus is a major cause of liver disease in Senegal.
机译:乙型病毒性肝炎是撒哈拉以南非洲地区的主要公共卫生问题,每年约有6500万慢性携带者和56000例死亡。我们的研究旨在调查在我科随访的乙型病毒性肝炎的流行病学旁临床,治疗和进化特征,并描述其血清学特征。我们于2010年至2014年在达喀尔阿里斯蒂德Le Dantec医院肝肠胃科进行了一项回顾性纵向研究。我们纳入了所有HBsAg阳性患者,均通过非卧床随访或住院治疗。我们从728例乙型肝炎病毒感染患者的病历中收集了数据:7例急性肝炎,442例慢性感染,161例肝硬化和118例肝细胞癌。患者的平均年龄为33岁[14-83岁],性别比为2.2。确诊的情况包括系统检查(26.2%),右软骨下痛(23%)和献血(18.6%)。有59例感染了乙型肝炎病毒并患有慢性活动性肝炎。无效的携带者为118人。252例患者的血清学状态未确定,原因是与经济限制有关的临床检查不足。 58例患者未进行抗病毒性乙型肝炎治疗。替诺福韦治疗120周后患者的病毒学和生化反应分别为85%和100%。乙型肝炎病毒是塞内加尔肝脏疾病的主要原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号